Mirum Pharmaceuticals (MIRM) Inventory Average (2022 - 2026)

Mirum Pharmaceuticals' Inventory Average history runs 5 years deep, the most recent figure standing at $25.2 million for Q1 2026.

• In Q1 2026, Inventory Average rose 12.46% year-over-year to $25.2 million; the TTM figure through Mar 2026 stood at $25.2 million (up 12.46% YoY), while the FY2025 annual figure was $23.6 million, up 5.76% from the prior year.
• Inventory Average was $25.2 million for Q1 2026 at Mirum Pharmaceuticals, up from $24.5 million in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $25.2 million in Q1 2026 to a low of $1.5 million in Q1 2022.
• Historically, Inventory Average has averaged $16.0 million across 5 years, with a median of $21.0 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Inventory Average surged 293.73% in 2023, then dropped 1.27% in 2024.
• A 5-year view of Inventory Average shows it stood at $6.3 million in 2022, then soared by 256.27% to $22.3 million in 2023, then fell by 1.27% to $22.0 million in 2024, then rose by 11.16% to $24.5 million in 2025, then advanced by 3.06% to $25.2 million in 2026.
• The last three Inventory Average figures came in at $25.2 million (Q1 2026), $24.5 million (Q4 2025), and $23.5 million (Q3 2025), per Business Quant data.